1 August 2025

Ropes & Gray Advises Matchpoint Therapeutics in Novartis Option and License Agreement Worth Up to $1 Billion

Advising firms

5 lawyers named

The named deal team is included with full access

Full access shows the lawyers on every deal team, disclosed values, clients and counterparties.

Deal value, client and counterparties are included with full access

Full access shows the disclosed value and what it refers to, the client and every counterparty.